Ichor Therapeutics, Inc., founded in Syracuse, NY, is a pre-clinical biotechnology company dedicated to developing therapeutic interventions for age-related diseases. The company's core mission is to pioneer innovative solutions for these conditions while also supporting biotech entrepreneurs and independent scientists through various ventures. Ichor offers a range of services as a full-service Contract Research Organization (CRO), combining the personalized approach of a small team with the extensive capabilities of a larger entity.
Notable figures affiliated with Ichor Therapeutics include its founder, Dr. Kelsey Moody, who has been instrumental in driving the company's vision forward. The company has garnered attention for its unconventional and dynamic approach to drug R&D, earning high praise from clients. Ichor's impact is significant in the biotech industry, particularly in reducing barriers for new entrants and advancing research in age-related diseases.
